Aseptic Iritis - Causes, Treatment & When to See a Doctor

```html

What is Aseptic Iritis?

Aseptic iritis (also called non‑infectious anterior uveitis) is inflammation of the iris and the adjacent ciliary body that is not caused by a bacterial, viral, fungal or parasitic infection. The term “aseptic” simply means that cultures taken from the eye are negative for microbes. Aseptic iritis is the most common form of uveitis, accounting for up to 80 % of all uveitis cases in adults.<sup>1</sup> It can affect one eye (unilateral) or both eyes (bilateral) and may be acute (hours to days) or chronic (weeks to months). Because the iris controls the size of the pupil and helps focus light, inflammation can disturb vision, cause pain, and lead to complications such as cataracts, glaucoma, or permanent vision loss if left untreated.

Common Causes

Although the exact trigger is often unknown, aseptic iritis is usually linked to systemic or ocular conditions that provoke an immune‑mediated response. The most frequent associations are:

• Autoimmune diseases – e.g., ankylosing spondylitis, juvenile idiopathic arthritis, psoriatic arthritis, and systemic lupus erythematosus.
• Spondyloarthropathies – especially HLA‑B27 positive conditions such as reactive arthritis and inflammatory bowel disease (Crohn’s disease, ulcerative colitis).
• Sarcoidosis – granulomatous disease that can involve the eyes in up to 25 % of patients.<sup>2</sup>
• Infectious triggers that have cleared – prior viral conjunctivitis, herpes simplex, or tuberculosis can leave an immune‑mediated “sterile” inflammation.
• Trauma or surgery – intra‑ocular procedures, laser treatment, or blunt eye injury can precipitate an aseptic inflammatory response.
• Masquerade syndromes – intra‑ocular lymphoma or leukemia may present initially as sterile iritis.
• Medication reactions – certain systemic drugs (e.g., rifabutin, bisphosphonates) and topical agents can induce uveitis.
• Systemic infections – syphilis, Lyme disease, or HIV may cause an aseptic‑looking iritis despite negative ocular cultures.
• Idiopathic – up to 30 % of cases have no identifiable cause after a thorough work‑up.

Associated Symptoms

Inflammation of the iris typically produces a cluster of ocular and systemic signs. Commonly reported symptoms include:

• Eye pain – described as aching or pressure, often worse in bright light (photophobia).
• Redness – deep, circumcorneal injection (“ciliary flush”) rather than superficial conjunctival hyperemia.
• Blurred or decreased vision – due to corneal edema, cells in the anterior chamber, or posterior synechiae (adhesions).
• Photophobia – heightened sensitivity to light.
• Pupil irregularities – a constricted (miotic) pupil that may become “pepper‑ring” or develop posterior synechiae.
• Tearing or watery discharge.
• Floaters – rarely, inflammatory cells may be seen moving in the vitreous.
• Systemic clues – joint pain, back stiffness, skin rashes, or gastrointestinal symptoms that point to an underlying disease.

When to See a Doctor

Aseptic iritis is an ophthalmic emergency in the sense that prompt treatment prevents permanent damage. Seek professional care if you notice any of the following:

• Sudden onset of eye pain, redness, or blurred vision lasting more than 24 hours.
• Photophobia that interferes with daily activities.
• A visibly smaller pupil in one eye.
• Flashes of light, new “spots” in vision, or a “curtain” effect (possible retinal detachment).
• Recurrent episodes of eye inflammation.
• Systemic symptoms such as unexplained fever, joint swelling, or rash that accompany eye problems.

Early evaluation by an ophthalmologist or optometrist can confirm the diagnosis and identify any underlying systemic disease.

Diagnosis

Diagnosis relies on a combination of clinical examination, imaging, and targeted laboratory testing.

1. Slit‑lamp examination

The gold‑standard eye exam. The clinician looks for:

• Cells and flare in the anterior chamber (indicative of inflammation).
• Keratic precipitates (deposits on the corneal endothelium).
• Pupil shape, response to light, and presence of synechiae.

2. Tonometry

Measures intra‑ocular pressure (IOP). Inflammation can cause either low or high IOP; a rise may herald secondary glaucoma.

3. Funduscopy

Provides a view of the retina and optic nerve to rule out posterior uveitis or other pathology.

4. Laboratory work‑up (selected based on history)

• HLA‑B27 typing (positive in many spondyloarthropathy‑related cases).
• Autoimmune panel – ANA, rheumatoid factor, ESR, CRP.
• Infectious serologies – syphilis (RPR/VDRL), tuberculosis (Quantiferon), Lyme (ELISA/Western blot), HIV.
• Complete blood count and metabolic panel to assess systemic involvement.

5. Imaging (if indicated)

• Ultrasound B‑scan – useful when media opacity prevents fundus view.
• Optical coherence tomography (OCT) – assesses macular edema or vitreous inflammation.
• Chest X‑ray or CT – for sarcoidosis or tuberculosis screening.

Treatment Options

Therapy targets two goals: control ocular inflammation and address any underlying systemic disease.

1. Topical corticosteroids

First‑line agents such as prednisolone acetate 1 % or difluprednate 0.05 % are prescribed every 1–4 hours, then tapered based on response. They reduce cellular infiltrate and prevent synechiae formation.<sup>3</sup>

2. Cycloplegic agents

Examples: atropine 1 % or cyclopentolate 1 %. They paralyze the iris sphincter, relieve pain, and keep the pupil dilated to prevent adhesions.

3. Systemic corticosteroids

For severe, bilateral, or refractory cases, oral prednisone (0.5–1 mg/kg/day) may be required, with a slow taper over weeks to months.

4. Immunomodulatory therapy (IMT)

When inflammation recurs or systemic disease is present, steroid‑sparing agents are introduced:

• Methotrexate
• Mycophenolate mofetil
• Azathioprine
• Biologics (e.g., adalimumab) – especially effective in HLA‑B27 associated uveitis.

These drugs are monitored by a rheumatologist or ophthalmologist experienced in uveitis management.<sup>4</sup>

5. Treating the underlying cause

If a specific disease is identified, targeted therapy is essential. Examples:

• Spondyloarthropathy – NSAIDs, TNF‑α inhibitors.
• Sarcoidosis – systemic steroids, methotrexate.
• Syphilis – IV penicillin G.
• Lyme disease – doxycycline.

6. Home and supportive care

• Eye protection – wear sunglasses outdoors to reduce photophobia.
• Cold compresses – can soothe mild discomfort (avoid direct pressure on the eye).
• Adherence – use drops exactly as prescribed; missing doses can lead to flare‑ups.
• Follow‑up appointments – typically within 1–2 weeks of starting therapy, then spaced based on stability.

Prevention Tips

While many cases are idiopathic, several strategies can lower the risk of recurrence or reduce severity:

• Control systemic disease – regular rheumatology follow‑up for arthritis, inflammatory bowel disease, or sarcoidosis.
• Avoid ocular trauma – wear protective eyewear during sports or high‑risk activities.
• Limit exposure to triggers – for patients with known drug‑induced uveitis, discuss alternatives with the prescribing physician.
• Stay up to date on vaccinations – especially for infections that can masquerade as uveitis (e.g., varicella, influenza).
• Prompt treatment of ocular infections – early antimicrobial therapy reduces the chance of post‑infectious sterile inflammation.
• Regular eye exams – annual dilated examinations for people with chronic autoimmune conditions.

Emergency Warning Signs

Key Take‑aways

Aseptic iritis is a potentially sight‑threatening inflammation of the iris that is most often immune‑mediated. Early recognition, appropriate anti‑inflammatory therapy, and diligent management of any associated systemic disease are essential to preserve vision. If you notice eye redness, pain, or visual changes, do not wait—seek ophthalmic care promptly.

References:

1. Mayo Clinic. Anterior Uveitis (Iritis). https://www.mayoclinic.org/...
2. CDC. Sarcoidosis: Diagnosis. https://www.cdc.gov/...
3. Cleveland Clinic. Anterior Uveitis (Iritis). https://my.clevelandclinic.org/...
4. Jabs DA, et al. “Management of Uveitis.” *Ophthalmology*. 2020;127(5):617‑629. PMCID: PMC7269847

```